Effectiveness of Different Progestin Modalities Compared to Other Hormonal Therapies for Endometriosis: A Systematic Review

Effectiveness of Different Progestin Modalities Compared to Other Hormonal Therapies for Endometriosis: A Systematic Review

Objective: A systematic review was conducted with a study compilation of women with endometriosis in determining the evidence of the use of various progestin modalities compared to other hormonal therapies in improving endometriosis-associated pain, enhancing quality of life (QoL) and minimizing ad...

Full description

Saved in:

Bibliographic Details
Main Authors:	Siti Azira Putri, Raissa Nurwany, Iche Andriyani Liberty
Format:	Article
Language:	English
Published:	Faculty of Medicine Siriraj Hospital 2025-06-01
Series:	Siriraj Medical Journal
Subjects:	Endometriosis progestin hormonal therapy
Online Access:	https://he02.tci-thaijo.org/index.php/sirirajmedj/article/view/272256
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparison of quality of life in patients with endometriosis undergoing treatment with progestins, oral contraceptives pills (OCP), and GnRH agonists
by: Mania Kaveh, et al.
Published: (2025-08-01)

Contraceptive progestins with androgenic properties stimulate breast epithelial cell proliferation
by: Marie Shamseddin, et al.
Published: (2021-05-01)

The role of long non-coding ribonucleic acid HOXA11-AS in endometriosis therapy
by: Ramanaiah Mamillapalli, et al.
Published: (2025-06-01)

RETRACTED ARTICLE: The comparison of two different protocols ultra-long versus medroxyprogesterone acetate in women with ovarian endometriosis: a prospective randomized controlled trial
by: Haiyan Guo, et al.
Published: (2022-10-01)

A patient and physician friendly stimulation protocol using long acting FSH and progestin priming should be the future of IVF
by: Einav Kadour-Peero, et al.
Published: (2022-03-01)

Recommendations on the management of meningioma and sex hormone therapy: The results of a collaborative effort between neurosurgical, endocrine and gynecological societies
by: Gilles Reuter, et al.
Published: (2025-01-01)

Medical treatment for adenomyosis: long term use of progestins
by: Silvia Vannuccini, et al.
Published: (2025-12-01)

Specifics of prescribing menopausal hormonal therapy in patients with the anamnestic endometriosis
by: M. I. Yarmolinskaya, et al.
Published: (2021-01-01)

Canagliflozin alleviates progestin resistance by suppressing RARβ/CRABP2 signaling in THRB knockout endometrial cancer cells
by: Ye Yang, et al.
Published: (2025-04-01)

A role of anti-Mullerian hormone in external genital endometriosis
by: A. S. Molotkov, et al.
Published: (2021-05-01)

Verification of the utility of the gonadotropin starting dose calculator in progestin‐primed ovarian stimulation: A comparison of empirical and calculated controlled ovarian stimulation
by: Masato Kobanawa, et al.
Published: (2024-01-01)

Smooth endoplasmic reticulum aggregates in oocytes: a comparison of progestin-primed and GnRH antagonist IVF protocols
by: Hsien-Ming Wu, et al.
Published: (2025-08-01)

Progestin-primed ovarian stimulation outcomes in in-vitro fertilization (IVF) – A systematic review of the literature
by: Vyacheslav Notanovich Lokshin, et al.
Published: (2024-12-01)

Endometriosis in Urology – an Update
by: Dan SPINU, et al.
Published: (2021-03-01)

The endogenous hydrogen gas (H2) drives women’s health: a comment on “Gut bacteria convert glucocorticoids into progestins in the presence of hydrogen gas”
by: Shuangling Yang, et al.
Published: (2025-02-01)

Determining the relationship between hormonal background characteristics and signs of female sexual dysfunction in women with and without endometriosis in the prediction of gestational success
by: L.M. Semeniuk, et al.
Published: (2025-05-01)

Systemic hormonal contraception and risk of venous thromboembolism
by: Oskari Heikinheimo, et al.
Published: (2022-08-01)

Effect of letrozole cotreatment in progestin-primed ovarian stimulation on IVF/ICSI outcomes in POSEIDON group 3 and 4 poor responders: a retrospective cohort study
by: Luyao Wang, et al.
Published: (2025-04-01)

Comparison of the euploidy rate in preimplantation genetic testing for aneuploidy cycles following progestin-primed versus gonadotropin-releasing hormone antagonist protocol: a randomized controlled study
by: Lu Wang, et al.
Published: (2025-05-01)

Co-existence of the abdominal wall and thoracic endometriosis: case report and literature review
by: Bo Gao, et al.
Published: (2025-05-01)

Endometriosis and the potential role of biomarkers in its diagnosis and treatment: A narrative review
by: Seyed Alireza Miraboutalebi, et al.
Published: (2023-12-01)

Progestin-primed ovarian stimulation for oocyte cryopreservation in patients with nonmedical indications: a case–control study
by: Ophélie Sounigo, et al.
Published: (2025-05-01)

ENDOMETRIOSIS AND FERTILITY. KEY MOMENT OF TREATMENT
by: S. A. Gasparyan, et al.
Published: (2016-06-01)

Progestin-Primed Ovarian Stimulation with Dydrogesterone Improves Oocyte and Embryo Outcomes in Women Undergoing In Vitro Fertilization: A Randomized Controlled Study
by: Trong Thach Than, et al.
Published: (2025-04-01)

Endometriosis in Focus: Modern Therapeutic Approaches for Enhanced Patient Outcomes - Review
by: Magda Piekarska, et al.
Published: (2024-10-01)

Physiological characteristics of reproductive-age patients with female sexual dysfunction and endometriosis (a comparison of clinical and laboratory parameters in different study groups)
by: O. I. Kryzhanovska, et al.
Published: (2024-05-01)

The natural evolution of untreated deep endometriosis and the effect of hormonal suppression: A systematic literature review and meta‐analysis
by: Veronica Bandini, et al.
Published: (2024-09-01)

Levonorgestrel intrauterine system versus oral progestin for preventing the recurrence of endometrial polyps after hysteroscopic resection: A meta-analysis of 19 randomized controlled trials
by: Y. Sun, et al.
Published: (2020-12-01)

Environmental gestagens: Current insights on ecotoxicity and microbial transformations
by: Prasiddhi Parab, et al.
Published: (2025-01-01)

Endometriosis and menopause—management strategies based on clinical scenarios
by: Ivika Jakson, et al.
Published: (2023-10-01)

Incisional Endometriosis: Four Clinical Cases
by: Tihomir Totev, et al.
Published: (2017-11-01)

Serum concentrations of medroxyprogesterone acetate were undetectable on OPU+5 days and had no effect on the serum progesterone level in patients undergoing the progestin-primed ovarian stimulation protocol
by: Xin Chen, et al.
Published: (2025-05-01)

The Role of Physical Activity in Reducing Endometriosis Pain
by: Emilia Bąk, et al.
Published: (2025-01-01)

INFLUENCE OF CHRONIC NEUROGENIC PAIN ON LOCAL LEVELS OF SEX HORMONES AND RECEPTORS IN SKIN, TUMOR AND PERIFOCAL AREA IN MALE MICE WITH TRANSPLANTABLE В16/F10 MELANOMA
by: E. M. Frantsiyants, et al.
Published: (2020-03-01)

PARTICULAR FEATURES OF OVARIAN CYSTS AND ENDOMETRIOSIS TREATMENT
by: I. S. Sidorova, et al.
Published: (2016-09-01)

Assessment of ovarian reserve function in patients with adenomyosis and ovarian endometriosis by three-dimensional transvaginal ultrasound and Anti-Müllerian hormone
by: Hui Yin, et al.
Published: (2024-12-01)

Diaphragmatic endometriosis associated with pelvic endometriosis: a case report
by: Rafael Tito Marques de Matos, et al.
Published: (2025-07-01)

Cumulative Live Birth Rates in Women Undergoing Progestin-Primed Ovarian Stimulation Using Medroxyprogesterone Acetate, Dydrogesterone, and Progesterone: A Retrospective Analysis
by: Wu F, et al.
Published: (2025-06-01)

Former long‐term use of combined hormonal contraception and glucose metabolism disorders in perimenopausal women: A prospective, population‐based cohort study
by: Maria‐Elina Mosorin, et al.
Published: (2023-11-01)

Polypoid endometriosis—An exceptional subtype of endometriosis mimicking an aggressive pelvic cancer
by: Katia Mahiou, et al.
Published: (2024-09-01)